Table 5.
Characteristics of study participants of the retrospective study at the baseline examination
| Total | |
|---|---|
| n | 368 |
| Age (years) | 65.5 ± 11.2 |
| Male | 199 (54.1) |
| Height (cm) | 161.1 ± 9.35 |
| Weight (kg) | 63.2 ± 12.7 |
| Body mass index (kg/m2) | 24.3 ± 3.97 |
| Body surface area (m2) | 1.66 ± 0.19 |
| Body composition | |
| Body fat mass (kg) | 18.8 ± 7.81 |
| Skeletal muscle mass (kg) | 24.1 ± 5.34 |
| Skeletal muscle index (kg/m2) | 6.92 ± 1.09 |
| ICW (kg) | 19.9 ± 4.14 |
| ECW (kg) | 12.7 ± 2.45 |
| ECW/ICW ratio | 0.64 ± 0.027 |
| ECW/TBW ratio | 0.392 ± 0.01 |
| HbA1c, mmol/mol (%) | 54.5 ± 11.0 (7.14 ± 1.01) |
| Creatinine (μmol/L) | 69.2 ± 20.0 |
| Urinary ACR (mg/gCr) | 109.0 ± 318.1 |
| Duration of diabetes (years) | 13.4 ± 10.2 |
| Smoking: never‐/ex‐/current smoker | 220/86/62 (59.8/23.3/16.8) |
| Exercise habit | 184 (50.0) |
| Usage of RAS inhibitor | 171 (46.5) |
| Use of insulin | 69 (18.9) |
| Use of SGLT‐2 inhibitor | 63 (17.1) |
| Use of diuretics | 31 (8.4) |
Data are expressed as the number (percentage) and mean ± standard deviation. ACR, albumin‐to‐creatinine ratio; ECW, extracellular water; ICW, intracellular water; RAS, renin–angiotensin–system; SGLT‐2, sodium–glucose cotransporter 2; TBW, total body water.